|
End-of-day quote
Taiwan S.E.
2026-11-06
|
5-day change | 1st Jan Change | ||
| 55.30 TWD | -1.95% |
|
-2.47% | +3.28% |
| Market Cap | 9.88B 301M 270M 247M 226M 425M 28.33B 438M 2.98B 1.19B 15.12B 1.13B 1.11B 47.73B | P/E 2024 |
12.6x | P/E 2025 | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 8.45B 258M 231M 211M 193M 363M 24.21B 375M 2.55B 1.01B 12.92B 967M 946M 40.79B | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.29x |
| Free-Float |
44.21% | Yield 2024 |
4.52% | Yield 2025 | 3.4% |
| 1 day | -1.95% | ||
| 1 week | -2.47% | ||
| Current month | -2.47% | ||
| 1 month | -1.07% | ||
| 3 months | -1.60% | ||
| 6 months | -0.77% | ||
| Current year | +3.28% |
| 1 week | 54.1 |  | 57.1 |
| 1 month | 54.1 | | 58.3 |
| Current year | 53.55 | | 60.55 |
| 1 year | 53.09 | | 60.55 |
| 3 years | 46.55 | | 72.18 |
| 5 years | 35.55 | | 72.36 |
| 10 years | 24.86 | | 72.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tzu-Ting Fan
CEO | Chief Executive Officer | - | 2006-05-29 |
Shu Hua Chen
IRC | Investor Relations Contact | - | - |
Wei Jen Chen
PRN | Corporate Officer/Principal | - | 2001-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Chin Tsai Fan
CHM | Chairman | - | 1967-06-29 |
Tsui Wen Yeh
BRD | Director/Board Member | - | 2002-05-28 |
Wen Chang Lin
BRD | Director/Board Member | - | 2023-06-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.95% | -2.47% | +7.10% | -1.41% | 305M | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,216B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 656B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 293B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 208B | |
| Average | -0.27% | -0.59% | +37.07% | +68.77% | 418.81B | |
| Weighted average by Cap. | -0.05% | -1.21% | +42.20% | +88.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.79B 207M 186M 170M 155M 292M 19.47B 301M 2.05B 816M 10.39B 777M 761M 32.79B | 7.02B 214M 192M 176M 160M 302M 20.14B 312M 2.12B 844M 10.74B 804M 787M 33.92B |
| Net income | 881M 26.86M 24.09M 22.01M 20.1M 37.86M 2.52B 39.05M 265M 106M 1.35B 101M 98.64M 4.25B | 928M 28.29M 25.38M 23.19M 21.17M 39.89M 2.66B 41.15M 280M 111M 1.42B 106M 104M 4.48B |
| Net Debt | -1.24B -37.93M -34.02M -31.09M -28.38M -53.47M -3.57B -55.16M -375M -149M -1.9B -142M -139M -6.01B | -1.44B -43.81M -39.29M -35.91M -32.78M -61.76M -4.12B -63.7M -433M -173M -2.2B -164M -161M -6.94B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | NT$55.30 | -1.95% | 508,401 |
| 26-11-05 | NT$56.40 | +0.36% | 400,210 |
| 26-11-04 | NT$56.20 | +0.18% | 247,351 |
| 26-11-03 | NT$56.10 | -1.06% | 218,801 |
| 26-11-02 | NT$56.70 | 0.00% | 104,619 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1720 Stock
Select your edition
All financial news and data tailored to specific country editions
